glp 1 cognitive benefits Could diabetes and weight loss drugs treat Alzheimer's disease? The expanding role of GLP-1
Description
Animal studies have shown potential risks with GLP-1 drugs during pregnancy, and these medications should be discontinued before conception if possible

Life Sci (2013) 92(10):53340.10.1016/j.lfs.2013.01.001 26 MabilleauGMieczkowskaAIrwinNFlattPRChappardD

8 Goal weight achieved Patients who achieve their goal weight may no longer wish to continue with their treatments, despite the evidence that rebound weight gain is common

Specific measures like safety, effectiveness, and dosing for AUD still need to be tested and confirmed

A variety of GLP-1RAs agents are currently available, including exenatide, liraglutide, dulaglutide, albiglutide, lixisenatide, semaglutide, and the dual GLP-1/GIP receptor agonist, tirzepatide
